Tumor angiogenesis: molecular pathways and therapeutic targets

SM Weis, DA Cheresh - Nature medicine, 2011 - nature.com
As angiogenesis is essential for tumor growth and metastasis, controlling tumor-associated
angiogenesis is a promising tactic in limiting cancer progression. The tumor …

Normalization of the vasculature for treatment of cancer and other diseases

S Goel, DG Duda, L Xu, LL Munn… - Physiological …, 2011 - journals.physiology.org
New vessel formation (angiogenesis) is an essential physiological process for embryologic
development, normal growth, and tissue repair. Angiogenesis is tightly regulated at the …

The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by tumor-vascular disrupting agents

DW Siemann - Cancer treatment reviews, 2011 - Elsevier
The vasculature of solid tumors is fundamentally different from that of normal vasculature
and offers a unique target for anti-cancer therapy. Direct vascular-targeting with Tumor …

HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF

C Rolny, M Mazzone, S Tugues, D Laoui, I Johansson… - Cancer cell, 2011 - cell.com
Polarization of tumor-associated macrophages (TAMs) to a proangiogenic/immune-
suppressive (M2-like) phenotype and abnormal, hypoperfused vessels are hallmarks of …

VEGF and angiopoietin signaling in tumor angiogenesis and metastasis

P Saharinen, L Eklund, K Pulkki, P Bono… - Trends in molecular …, 2011 - cell.com
Solid tumors require blood vessels for growth and dissemination, and lymphatic vessels as
additional conduits for metastatic spread. The identification of growth factor receptor …

[HTML][HTML] The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non …

RM Bremnes, K Al-Shibli, T Donnem, R Sirera… - Journal of Thoracic …, 2011 - Elsevier
In addition to malignant neoplastic cells, cancer tissues also include immune cells,
fibroblasts, and endothelial cells, including an abundant collection of growth factors …

Molecular pathways in cancer-related inflammation

A Dep Prete, P Allavena, G Santoro, R Fumarulo… - Biochemia …, 2011 - hrcak.srce.hr
Sažetak Accumulating evidence shows that chronic inflammation is associated to increased
risk of cancer. An inflammatory component is present also in the microenvironment of …

DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo

JL Li, RCA Sainson, CE Oon, H Turley, R Leek… - Cancer research, 2011 - AACR
Resistance to VEGF inhibitors is emerging as a major clinical problem. Notch signaling has
been implicated in tumor angiogenesis. Therefore, to investigate mechanisms of resistance …

Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study

JF De Groot, KR Lamborn, SM Chang… - Journal of Clinical …, 2011 - ascopubs.org
Purpose Antivascular endothelial growth factor (anti-VEGF) therapy is a promising treatment
approach for patients with recurrent glioblastoma. This single-arm phase II study evaluated …

VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting

S Oladipupo, S Hu, J Kovalski, J Yao… - Proceedings of the …, 2011 - National Acad Sciences
Although our understanding of the molecular regulation of adult neovascularization has
advanced tremendously, vascular-targeted therapies for tissue ischemia remain suboptimal …